Old Web
English
Sign In
Acemap
>
authorDetail
>
Meir Azulay
Meir Azulay
Weizmann Institute of Science
Immunology
Immune system
Biology
Immunity
Cytotoxic T cell
4
Papers
30
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Characterization of BAY 1905254, an immune checkpoint inhibitor targeting the immunoglobulin-like domain containing receptor 2 (ILDR2).
2020
Cancer immunology research
Julia Huetter
Uwe Gritzan
Ilona Gutcher
Wolf-Dietrich Doecke
Merlin Luetke-Eversloh
Sven Golfier
Helge Gottfried Roider
Anna-Lena Frisk
John Joseph Hunter
Andrew Pow
Andrew W. Drake
Zurit Levine
Ofer Levy
Meir Azulay
Inbal Barbiro
Gady Cojocaru
Ilan Vaknin
Bertolt Kreft
Lars Roese
Show All
Source
Cite
Save
Citations (2)
Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity
2014
Cancer Immunology, Immunotherapy
Zoya Alteber
Meir Azulay
Gal Cafri
Ezra Vadai
Esther Tzehoval
Lea Eisenbach
Show All
Source
Cite
Save
Citations (16)
Split Immunity: Immune Inhibition of Rat Gliomas by Subcutaneous Exposure to Unmodified Live Tumor Cells
2011
Journal of Immunology
Ilan Volovitz
Yotvat Marmor
Meir Azulay
Arthur Machlenkin
Ofir Goldberger
Felix Mor
Shimon Slavin
Zvi Ram
Irun R. Cohen
Lea Eisenbach
Show All
Source
Cite
Save
Citations (12)
Unmodified Live Tumor Cells Gliomas by Subcutaneous Exposure to Split Immunity : Immune Inhibition of Rat
2011
Zvi Ram
Irun R. Cohen
Lea Eisenbach
Machlenkin
Ofir Goldberger
Felix Mor
Shimon Slavin
Ilan Volovitz
Yotvat Marmor
Meir Azulay
Show All
Source
Cite
Save
Citations (0)
1